Protalix BioTherapeutics, Inc. (PLX) [Rocket]

Date Filed	Type	Description
07/07/2023	424B3	Form 424B3 - Prospectus [Rule 424(b)(3)]:
02/27/2023	424B5	Form 424B5 - Prospectus [Rule 424(b)(5)]:
05/02/2022	424B5	Form 424B5 - Prospectus [Rule 424(b)(5)]:
07/02/2021	424B5	Form 424B5 - Prospectus [Rule 424(b)(5)]:
07/02/2021	424B5	Form 424B5 - Prospectus [Rule 424(b)(5)]:
02/16/2021	424B5	Form 424B5 - Prospectus [Rule 424(b)(5)]:
02/11/2021	424B5	Form 424B5 - Prospectus [Rule 424(b)(5)]:
10/01/2020	424B5	Form 424B5 - Prospectus [Rule 424(b)(5)]:
04/29/2020	424B3	Form 424B3 - Prospectus [Rule 424(b)(3)]:
02/16/2012	424B5	Form 424B5 - Prospectus [Rule 424(b)(5)]
03/18/2011	424B5	Form 424B5 - Prospectus [Rule 424(b)(5)]
03/17/2011	424B5	Form 424B5 - Prospectus [Rule 424(b)(5)]
03/30/1998	424B3	Form 424B3 -- Prospectus [Rule 424(b)(3)]